System | 22q11.2DupS with documentation of evaluation | Percent abnormal of those with evaluation | Comments | 22q11.2DS with documentation of evaluation; Percent abnormal |
---|---|---|---|---|
Cardiac | Clinical evaluation: n = 37 | 24 % (9/37) | VSD, PVS, PDA, ASD/PFO, TOF, HLHS | Clinical evaluation by echo: n = 99; 82 % abnormal |
Echo: n = 25 | ||||
Endocrine | Endocrine evaluation: n = 31 | Hypothyroidism 19 % (6/31) Hypocalcemia 10 % (3/31) | Endocrine evaluation: n = 98; 70 % abnormal (including 16 % with hypothyroidism and 38 % with hypocalcemia) | |
Hearing loss | Audiogram: n = 37 | 16 % (6/37) • Conductive n = 3 • Mixed n = 2 • Sensorineural n = 1 | Mild loss in 4/5; Mild to moderate loss in 1/5 with Mixed HL | Audiogram: n = 101; 34 % abnormal (including 26 % with Conductive HL, 3 % with sensorineural; 2 % with HL not specified) |
Hematologic | Complete blood count: n = 37 | 16 % (6/37) • Thrombocytopenia n = 1 • Thrombocytopenia and anemia n = 1 • Neutropenia n = 2 • Anemia n = 2 | Prolonged PTT in patient with Factor XII deficiency not included | Complete blood count: n = 101; 23 % abnormal (including 12 % with thrombocytopenia) |
Immunologic | Immunology visit: n = 31 | 39 % (12/31) • Abnormal immunoglobulin levels n = 7 • Inappropriate vaccine response n = 3 • Low T-cell count n = 1 • CVID n = 1 | Immunology visit: n = 98; 66 % abnormal | |
Neurologic/calavarium | Brain MRI: n = 16 | Structural anomaly 24 % (5/21) | Chiari Type I; Prominent posterior CSF space, platybasia, T2 prolongation in hippocampus; Sagittal synostosis | Neurological evaluation: n = 50; 40 % abnormal (including 15 % with seizure disorder) |
EEG: n = 5 | Hypotonia 27 % (10/37) | |||
Seizure activity 19 % (7/37) | ||||
Ophthalmologic | Ophthalmology evaluation: n = 37 | 22 % (8/37) • Strabismus n = 5 • Megalocornea n = 1 • Aphakia and congenital cataract n = 1 • Ptosis n = 1 | Ophthalmology evaluation: n = 56; 48 % abnormal (including 23 % with strabismus) | |
Otolaryngology(non-palate related) | Otolaryngology evaluation: n = 37 | 54 % (20/37) | Ankyloglossia, dysphagia, laryngomalacia, Eustachian tube dysfunction. Surgical interventions: BMT (n = 9), T&A (n = 9) | Otolaryngology evaluation: n = 93; 83 % abnormal (including 59 % requiring BMTs and 20 % requiring T&A) |
Renal | Renal ultrasound: n = 25 | 24 % (6/25) | VUR; Pelviectasis (n = 2); Lithiasis; Nephromegaly; Megaureter | Renal ultrasound: n = 95; 23 % abnormal |
Skeletal | C-Spine x-rays: n = 11 | C-spine anomaly 45 % (5/11) | Slightly large atlantodens interval; Hypoplastic PE of C1 and elongated PE of C2; Exaggerated kyphosis, lordosis; Incomplete arch C1; Lack of bony fusion of C1 and dysmorphic C2 | C-Spine x-ray: n = 59; 71 % abnormal (27 % with C2-C3 fusion). Hemihypertrophy noted in 1/101. |
Hemihypertophy noted in 3/37 |